ReproCyc PRRS EU inj. susp. (lyoph.) i.m. vial

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Porcine Reproductive and Respiratory Syndrome Virus (Live, Attenuated)

Disponibbli minn:

Boehringer Ingelheim Vetmedica GmbH

Kodiċi ATC:

QI09AD03

INN (Isem Internazzjonali):

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

Għamla farmaċewtika:

Lyophilisate and solvent for suspension for injection

Kompożizzjoni:

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

Rotta amministrattiva:

Intramuscular use

Grupp terapewtiku:

pig

Żona terapewtika:

Porcine Reproductive and Respiratory Syndrome (PRRS) Virus

Sommarju tal-prodott:

CTI code: 474880-06 - Pack size: 25 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-04 - Pack size: 25 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-05 - Pack size: 25 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-02 - Pack size: 12 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-03 - Pack size: 12 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-01 - Pack size: 12 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

2015-06-16